November 5, 2024
TOPLINE: Nearly all patients reported receiving instructions to take levothyroxine (LT4) while fasting, but a third did not adhere to this. Approximately half of patients reported […]
November 5, 2024
Editor’s note: This story has been revised to include additional comments. CHICAGO — In patients with stage IVB anaplastic thyroid cancer, the inclusion of adjuvant pembrolizumab […]
November 5, 2024
SAN ANTONIO, Texas — An upcoming document will entirely reframe obesity as a “condition of excess adiposity” that constitutes a disease called “clinical obesity” when related […]
November 5, 2024
TOPLINE: In women with polycystic ovary syndrome (PCOS) and with obesity or overweight, the combination of topiramate and metformin along with a low-calorie diet can result […]
November 4, 2024
LONDON (Reuters) -AstraZeneca said on Monday its experimental weight-loss pill, licensed a year ago from China’s Eccogene for up to $2 billion, was safe and tolerable […]
November 4, 2024
SAN ANTONIO — Treatment with once-weekly semaglutide 2.4 mg (Wegovy) significantly reduced hospital admissions for all causes — not just cardiac — and overall hospitalization time […]
November 4, 2024
CHICAGO — The investigational monoclonal antibody batoclimab showed safety and rapid and significant improvement in key markers of Graves’ disease, with some patients who failed to […]
November 4, 2024
(Reuters) – Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk’s weight-loss and diabetes drugs but cannot always fill them because of supply […]
November 4, 2024
The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging procedures, […]